Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197963 · ClinicalTrials.gov registry record · NA
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01197963 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 3 participants.
The verdict
NCT01197963, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if by performing surgery we can cure Type II Diabetes. The surgical procedures: 1. a sleeve gastrectomy, cutting out a portion of the stomach, which provides restriction of caloric intake and rapid gastric emptying. 2. ileal transposition which involves repositioning a 150cm segment of the ileum into the jejunum causing improved glucose homeostasis.
Interventions
- PROCEDURE Sleeve Gastrectomy and Ileal transposition
- DIETARY_SUPPLEMENT dietary and medical management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197963
The ClinicalTrials.gov registry entry for NCT01197963 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleeve Gastrectomy and Ileal transposition is the first listed.
NCT01197963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197963 about?
NCT01197963 is a clinical study titled "A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2". The purpose of the study is to determine if by performing surgery we can cure Type II Diabetes. The surgical procedures: 1. a sleeve gastrectomy, cutting out a portion of the stomach, which provides restriction of caloric intake and rapid gastric emptying. 2. ileal transposition which involves rep...
What is the current status of trial NCT01197963?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2010-09. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01197963?
The interventions under investigation include: Sleeve Gastrectomy and Ileal transposition (PROCEDURE), dietary and medical management (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01197963?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.